Peripheral vascular disorder therapeutics - Alucent Medical

Drug Profile

Peripheral vascular disorder therapeutics - Alucent Medical

Alternative Names: Natural vascular scaffold therapy; NVS therapy

Latest Information Update: 06 Jul 2017

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Alumend
  • Class Vascular disorder therapies
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I Peripheral vascular disorders

Most Recent Events

  • 25 May 2017 Phase-I clinical trials in Peripheral vascular disorders in USA (Intra-arterial) (NCT03148808)
  • 24 May 2017 Alucent Medical plans a phase I trial for Peripheral vascular disorders in USA (NCT03148808)
  • 16 May 2017 Preclinical trials in Peripheral vascular disorders in USA (Intra-arterial)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top